Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Rabeprazole sodium

SKU: orb1307891

Description

Rabeprazole Sodium is a proton pump inhibitor derived from timoprazole, used to treat gastric ulcers and Zollinger-Ellison syndrome by inhibiting H+/K+ ATPase in parietal cells. It is widely applied in pharmacological research for investigating gastric acid secretion in both in vitro cellular models and in vivo animal studies.

Research Area

Cell Biology, Infectious Disease & Virology, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number117976-90-6
MW381.42
Purity99.91% (May vary between batches)
FormulaC18H20N3NaO3S
SMILESc12c([n-]c(n1)S(=O)Cc1c(c(ccn1)OCCCOC)C)cccc2.[Na+]
TargetApoptosis,Proton pump,Antibacterial
SolubilityEthanol:71 mg/mL (186.15 mM);H2O:1.34 mg/mL (3.51 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.24 mM);DMSO:58.82 mg/mL (154.21 mM)

Bioactivity

Target IC50
UNH:0.3 μM (IC50)
In Vivo
Rabeprazole does not appear to exacerbate bone metabolic disorders in gastrectomized rats, but rather ameliorates the TG-induced BMD decrease.
In Vitro
Administration of rabeprazole leads to a marked decrease in the viability of MKN-28 cells. Exposure to rabeprazole induces significant apoptosis in AGS cells. Rabeprazole completely inhibits the phosphorylation of ERK 1/2 in the MKN-28 cells, whereas the same effect is not observed in either the KATO III or MKN-45 cells. Rabeprazole is able to efficaciously inhibit the phosphorylation of ERK 1/2 in the gastric cancer cells.Thus, rabeprazole can attenuate the cell viability of human gastric cancer cells through inactivation of the ERK1/2 signaling pathway.
Cell Research
Rabeprazole is administrated to three gastric cancer cell lines, KATO III, MKN-28 and MKN-45, at a dosage of 0.2 mM for 16 h. The viability of these cells is determined by a trypan blue exclusion assay.(Only for Reference)

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Aciphex Sodium, Apoptosis, Dexrabeprazole Sodium, nucleoside, LY307640, LY307640 sodium, LY-307640, LY 307640, Habeprazole Sodium, gastroesophageal, gastric, reflux, Rebeprazole sodium, PPI, Rabeprazole, Rabeprazole sodium, proton, Protonpump, Proton pump, Proton Pump, pump, ribohydrolase, ulcerations, UNH

Similar Products

  • Rebeprazole sodium [orb1226867]

    >98% (HPLC)

    117976-90-6

    381.42

    C18H20N3NaO3S

    5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

100 mg
200 mg
1 ml x 10 mM (in DMSO)
$ 70.00